Zoetis Inc. (ZTS): Gross Profit
$6.80B
Year ended 2025-12-31
+6.5%
3-year compound annual growth
+8.0%
5-year compound annual growth
+8.4%
10-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.80B | +4.0% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | $6.54B | +9.3% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $5.98B | +6.3% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | $5.63B | +2.8% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $5.47B | +18.5% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $4.62B | +8.2% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $4.27B | +9.0% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $3.91B | +10.8% | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | $3.53B | +9.6% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $3.22B | +6.4% | 2019-02-14, From 2016-01-01 |
| 2015-12-31 | $3.03B | -1.3% | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $3.07B | +6.1% | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | $2.89B | +4.3% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $2.77B | +7.4% | 2015-02-27, From 2012-01-01 |
| 2011-12-31 | $2.58B | n/a | 2014-03-26, From 2011-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Zoetis Inc. (ZTS) | 2025-12-31 | $6.80B | +4.0% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $10.35B | +9.1% |
| Viatris Inc (VTRS) | 2025-12-31 | $5.01B | -10.8% |
| Organon & Co. (OGN) | 2025-12-31 | $3.31B | -10.8% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.67B | +45.3% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $8.94B | +10.8% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $2.59B | +6.4% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $1.49B | -3.1% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $3.04B | +56.4% |
Compare ZTS, VRTX, VTRS, OGN side by side · Screen every company in Pharmaceutical Preparations ↗